Display options
Cite
Strowd SM, Majewski MB, Asteris J. Malignant Hyperthermia Versus Thyroid Storm in a Patient With Symptomatic Graves Disease: A Case Report. A A Pract. 2018;10(5):97-99doi: 10.1213/XAA.0000000000000639.
Strowd, S. M., Majewski, M. B., & Asteris, J. (2018). Malignant Hyperthermia Versus Thyroid Storm in a Patient With Symptomatic Graves Disease: A Case Report. A&A practice, 10(5), 97-99. https://doi.org/10.1213/XAA.0000000000000639
Strowd, Sara M, et al. "Malignant Hyperthermia Versus Thyroid Storm in a Patient With Symptomatic Graves Disease: A Case Report." A&A practice vol. 10,5 (2018): 97-99. doi: https://doi.org/10.1213/XAA.0000000000000639
Strowd SM, Majewski MB, Asteris J. Malignant Hyperthermia Versus Thyroid Storm in a Patient With Symptomatic Graves Disease: A Case Report. A A Pract. 2018 Mar 01;10(5):97-99. doi: 10.1213/XAA.0000000000000639. PMID: 29028638.
Copy Download .nbib Format: NLM
Share it on

A A Pract. 2018 Mar 01;10(5):97-99. doi: 10.1213/XAA.0000000000000639.

Malignant Hyperthermia Versus Thyroid Storm in a Patient With Symptomatic Graves Disease: A Case Report.

A&A practice

Sara M Strowd, Michael B Majewski, Jennifer Asteris

Affiliations

  1. From the Department of Anesthesiology, Loyola University Medical Center, Maywood, Illinois.

PMID: 29028638 DOI: 10.1213/XAA.0000000000000639

Abstract

Malignant hyperthermia and thyroid storm are intraoperative emergencies with overlapping symptoms but different treatment protocols. We faced this diagnostic dilemma in a 25-year-old patient with symptomatic hyperthyroidism, elevated free T3 and free T4, and low thyroid-stimulating hormone from Graves disease despite treatment with propranolol 80 mg daily and methimazole 40 mg every 8 hours. During thyroidectomy, he developed hyperthermia and hypercarbia without tachycardia. When the rate of rise of PaCO2 and temperature accelerated, we treated the patient for malignant hyperthermia, a diagnosis subsequently confirmed by genetic testing.

References

  1. Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K. Malignant hyperthermia: a review. Orphanet J Rare Dis. 2015;10:93. - PubMed
  2. Kim DC. Malignant hyperthermia. Korean J Anesthesiol. 2012;63:391401. - PubMed
  3. Broman M, Heinecke K, Islander G. Screening of the ryanodine 1 gene for malignant hyperthermia causative mutations by high resolution melt curve analysis. Anesth Analg. 2011;113:11201128. - PubMed
  4. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993;22:263277. - PubMed
  5. O’Flynn RP, Shutack JG, Rosenberg H, Fletcher JE. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis. Anesthesiology. 1994;80:12281233. - PubMed
  6. De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016;388:906918. - PubMed
  7. Nahas GG, Sutin KM, Fermon C. Guidelines for the treatment of acidaemia with THAM. Drugs. 1998;55:191224. - PubMed

Publication Types